ReviewMini reviews in medicinal chemistry2024

HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors.

Totan Das et al.PubMed ↗Publisher ↗

No numbers read from the abstract.